Wang Ming, Yu Ting
Department of Anesthesiology, Beilun People's Hospital, Ningbo, Zhejiang, China.
Department of Pharmacy, Beilun People's Hospital, Ningbo, Zhejiang, China.
Front Public Health. 2025 Sep 11;13:1583812. doi: 10.3389/fpubh.2025.1583812. eCollection 2025.
The objective of this study was to assess the distribution and trends in the prevalence of drug use disorders (DUDs) among adolescents and young adults (aged 15 to 39 years), disaggregated by gender, region, country, and socio-demographic index (SDI), over the period from 1990 to 2021.
Utilizing data from GBD 2021, we estimated the incidence, disability-adjusted life years (DALYs), age-standardized incidence rates (ASIR), age-standardized DALY rates, and age-standardized death rates (ASDR) for DUDs among adolescents and young adults across 204 countries and 21 regions from 1990 to 2021. Additionally, we assessed the trend of the estimated annual percentage change (EAPC).
Globally, the ASIR of new DUD cases among adolescents and young adults exhibited a decreasing trend from 1990 to 2021, with an EAPC of -0.46 (95% confidence interval: -0.52, -0.39). In 2021, the highest ASIR, age-standardized DALY rate, and ASDR were observed in high SDI areas, while the lowest rates were found in low SDI areas. The above two SDI regions demonstrated an increasing trend from 1990 to 2021. The ASIR, age-standardized DALY rates and ASDR for DUDs were consistently higher among males than females across low SDI, middle and low SDI, medium SDI, and middle and high SDI areas. The three countries with the highest ASIR were the United States (1096.05), Estonia (854.62), and New Zealand (815.92). The countries with the highest age-standardized DALY rate were the United States (3520.13), Canada (1665.49), and Estonia (1602.04). The countries with the highest ASDR were the United States (26.86), Canada (13.92), and Iceland (8.85).
The disease burden of DUDs, measured by age-standardized DALY rates, varies across different SDI regions, with higher DALY rates observed in regions with high SDI. Additionally, gender plays a significant role in the distribution of this burden, with males experiencing a higher burden than females. Furthermore, there are distinct national and regional variations in the prevalence and trends of DUDs among adolescents and young adults.
本研究的目的是评估1990年至2021年期间,按性别、地区、国家和社会人口指数(SDI)分类的青少年和青年(15至39岁)药物使用障碍(DUDs)患病率的分布及趋势。
利用全球疾病负担研究(GBD)2021的数据,我们估算了1990年至2021年期间204个国家和21个地区青少年和青年中DUDs的发病率、伤残调整生命年(DALYs)、年龄标准化发病率(ASIR)、年龄标准化DALY率和年龄标准化死亡率(ASDR)。此外,我们评估了估计年度百分比变化(EAPC)的趋势。
全球范围内,1990年至2021年期间青少年和青年中新发DUD病例的ASIR呈下降趋势,EAPC为-0.46(95%置信区间:-0.52,-0.39)。2021年,高SDI地区的ASIR、年龄标准化DALY率和ASDR最高,而低SDI地区的这些比率最低。上述两个SDI地区在1990年至2021年期间呈上升趋势。在低SDI、中低SDI、中等SDI以及中高SDI地区,DUDs的ASIR、年龄标准化DALY率和ASDR在男性中始终高于女性。ASIR最高的三个国家是美国(1096.05)、爱沙尼亚(854.62)和新西兰(815.92)。年龄标准化DALY率最高的国家是美国(3520.13)、加拿大(1665.49)和爱沙尼亚(1602.04)。ASDR最高的国家是美国(26.86)、加拿大(13.92)和冰岛(8.85)。
以年龄标准化DALY率衡量的DUDs疾病负担在不同SDI地区有所不同,高SDI地区的DALY率更高。此外,性别在这种负担的分布中起重要作用,男性的负担高于女性。此外,青少年和青年中DUDs的患病率和趋势存在明显的国家和地区差异。